Researchers from The Children’s Hospital of Philadelphia and the Perelman School of Medicine at The University of Pennsylvania, along with colleagues at the Botswana-Baylor Children’s Clinical Centre of Excellence, conducted the first large-scale comparison the two drugs, efavirenz and nevirapine.
A groundbreaking clinical trial of gene therapy for a form of congenital blindness, sponsored by The Children’s Hospital of Philadelphia in collaboration with Penn Medicine, was recently recognized with the Distinguished Clinical Research Achievement Award from the Clinical Research Forum, an organization of clinical research centers, industry, and volunteer groups.
Pediatric cardiologist Paul M. Weinberg, MD, FAAC, received the 2013 Distinguished Teacher Award at the American College of Cardiology’s national conference, called ACC.13, on March 11 in San Francisco.
A new genetic study may shed light on the causes of the rare childhood disease biliary atresia. The leading cause of liver transplantation in children, biliary atresia (BA) is a rare, life-threatening condition in which the ducts that carry bile from the liver to the gallbladder become blocked. Children’s Hospital’s Randy Matthews, MD, PhD, led this new collaborative genetic study of BA, a condition occurring exclusively in neonatal livers.
A new genetic study offers glimpses into how scientists might use gene-sequencing data to customize pediatric patients’ cancer treatments.
We’re pleased to announce that during the 2012 Federal fiscal year, The Children’s Hospital of Philadelphia Research Institute received more NIH funding than any other independent children’s hospital. Children’s Hospital received more than $125 million in NIH funds in 2012, beating out Boston Children’s Hospital.
Flaura K. Winston, MD, PhD, the Center’s scientific director and founder, outlines a few resources families can use to help their children better understand and cope with disasters like the recent bombings in Boston.
A report on American Public Media’s Marketplace on DNA sequencing and its effect on (and creation of) personalized medicine — “the next big thing in health care” — featured input from CHOP’s Nancy B. Spinner, PhD.
Four junior investigators from the Children’s Hospital of Philadelphia’s Department of Pediatrics have been chosen to receive the prestigious 2013 Young Physician-Scientist Award by the American Society for Clinical Investigation (ASCI).
A physician-researcher from The Children’s Hospital of Philadelphia will lead the first-ever pediatric “Dream Team” solely focused on creating new treatments for the most challenging childhood cancers.